Tert-butyl N-[(1R,3R)-1-hydroxy-1-[4-(hydroxymethyl)-5-methyl-1,3-thiazol-2-yl]-4-methylpentan-3-yl]-N-methylcarbamate
C17H30N2O4S — CID 142601614
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[(1R,3R)-1-hydroxy-1-[4-(hydroxymethyl)-5-methyl-1,3-thiazol-2-yl]-4-methylpentan-3-yl]-N-methylcarbamate
Tert-butyl N-[(1R,3R)-1-hydroxy-1-[4-(hydroxymethyl)-5-methyl-1,3-thiazol-2-yl]-4-methylpentan-3-yl]-N-methylcarbamate (PubChem CID 142601614) has the molecular formula C17H30N2O4S and a molecular weight of 358.50 g/mol. Its IUPAC name is tert-butyl N-[(1R,3R)-1-hydroxy-1-[4-(hydroxymethyl)-5-methyl-1,3-thiazol-2-yl]-4-methylpentan-3-yl]-N-methylcarbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[(1R,3R)-1-hydroxy-1-[4-(hydroxymethyl)-5-methyl-1,3-thiazol-2-yl]-4-methylpentan-3-yl]-N-methylcarbamate |
|---|---|
| PubChem CID | 142601614 |
| Molecular Formula | C17H30N2O4S |
| Molecular Weight | 358.50 g/mol |
| Exact Mass | 358.19 |
| IUPAC Name | tert-butyl N-[(1R,3R)-1-hydroxy-1-[4-(hydroxymethyl)-5-methyl-1,3-thiazol-2-yl]-4-methylpentan-3-yl]-N-methylcarbamate |
| SMILES | Cc1sc([C@H](O)C[C@H](C(C)C)N(C)C(=O)OC(C)(C)C)nc1CO |
| InChI | InChI=1S/C17H30N2O4S/c1-10(2)13(19(7)16(22)23-17(4,5)6)8-14(21)15-18-12(9-20)11(3)24-15/h10,13-14,20-21H,8-9H2,1-7H3/t13-,14-/m1/s1 |
| InChIKey | NOZGYMPRGWCGLD-ZIAGYGMSSA-N |
| XLogP | 3.26 |
| TPSA | 82.89 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 358.50 |
| LogP ≤ 5 | 3.26 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142601614 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.